Partners
Our authorized partners support your R&D projects
TET Systems has built a network of authorized suppliers providing research tools and services to facilitate your R&D projects. Licensees have access to a broad range of reagents, services or animals comprising the Tet Technology.
Biospecimen Laboratories Co. Ltd. and TET Systems GmbH & Co. KG sign Marketing Agreement for the Tet Technology in Japan
Biospecimen Laboratories Co. Ltd., a privately-held, Japan-based trading and consulting company, and TET Systems GmbH & Co. KG, a privately-held, German-based biotech company, announced today that they have entered into a marketing agreement, effective July 1, 2024. This agreement will replace the previous marketing alliance between BizCom Japan, Inc. and TET Systems.
Biospecimen Laboratories Co. Ltd. (BSL), was founded by Dr. Hiroyasu Nakatani. During his time at BizCom Japan, Inc. Dr. Nakatani was the main representative for TET Systems (TET). He was instrumental in introducing the TET technology to the life science market in Japan and in establishing alliances with Japanese companies and public institutions. BSL will use his experience to exclusively market the Tet Technology for TET Systems GmbH & Co. KG in Japan.
TET would like to thank BizCom Japan, Inc. for its outstanding support both of Dr. Nakatani and TET Systems over the past years. All parties involved are convinced that Dr. Nakatani is the perfect solution to manage TET Systems` existing business and to form new relationships with Japanese customers.
NOTE TO JAPANESE CUSTOMERS:
From July 1, 2024, please contact:
Biospecimen Laboratories, Inc.
1-5-10-105, Nakamagome, Ota-ku Tokyo 143-0027
TEL: 03-3775-5155
Mail: license@biospecimen.co.jp
About Biospecimen Laboratories, Co. Ltd.
Biospecimen Laboratories Co. Ltd. is a trading and consulting company based in Tokyo, Japan.
About TET Systems GmbH & Co. KG
TET Systems GmbH & Co. KG is a privately held company located in Heidelberg, Germany. TET Systems GmbH & Co. KG was founded by Prof. Dr. H. Bujard and colleagues based on their invention of the TET Technology, the most widely used method to control gene expression in higher organisms. TET Systems GmbH & Co. KG owns a broad patent portfolio. To date, more than 500 organizations have licensed the TET Technology including large pharmaceutical companies, academic institutions or research foundations and are long-standing partners.
Services
Commercial licensee for
- Assay Development and screening: compound screening using tailored biochemical and cellular assays
- Integrated drug discovery: conducting gene-to-candidate discovery programs
Discovery from Charles River offers a comprehensive, integrated portfolio of services, including to support drug development from hit ID to IND.
Commercial worldwide license to use the Tet technology for custom services and custom products including DNA vectors, virus particles and transgenic cell lines
Commercial worldwide licensee for the production, the concentration and the purification of custom lentiviral vectors compositions comprising the Tet Technology.
Commercial worldwide license to use the Tet technology for custom viral vector product, and packaging & producer cells for custom vector manufacturing.
Global license to use the Tet Technology for custom cell line products and custom viral vectors in the area of pharmaceutical research and discoveries.
Global license to use the Tet Technology for custom stem cell line generation.
Reagents
Global licensed distributor of plasmids containing components of the Tet technology which are not commercially available.
Commercial worldwide license to use the Tet technology for custom services and custom products including DNA vectors, virus particles and transgenic cell lines
Commercial worldwide licensee for the production, the concentration and the purification of custom lentiviral vectors compositions comprising the Tet Technology.
Commercial worldwide license to use the Tet technology for custom viral vector product, and packaging & producer cells for custom vector manufacturing.
Commercial Licensee and preferred partner for more than 15 years for the sale of:
- Tet Systems reagents- including recent improvements of the Tet technology, such as the Tet On/Off Advanced System.
- Viral Delivery of Tet Systems - including lentivirus and adenovirus
- inducible shRNA/miRNA Tet Systems
Commercial worldwide licensee for the production of vector compositions comprising the Tet Technology.
Animals
Commercial worldwide licensee for the generation of customized transgenic mice and rats containing the Tet System. GenOway's marketing right is worldwide.
Commercial licensee for the generation of customized transgenic mice containing the Tet System.
Commercial licensee for the worldwide marketing of custom transgenic animals (including ES cells and embryos) Taconic Biosciences has been a leading provider of research models for 20 years with a singular mission: to create a difference in human health by generating, maintaining, breeding, and distributing the best, most relevant mouse and rat models to researchers in the life science community. By offering the most diverse array of transgenic technologies, including TET System, Taconic can design and generate the most appropriate model type tailored to your experimental needs.
Licensee for the receipt, maintenance, reproduction, use and distribution of laboratory animals which contain or are produced using the TET System.
Licensee for the receipt, reproduction, maintenance, use and distribution of laboratory animals which contain or are produced using the Tet System.
Licensee for the receipt, maintenance, reproduction, use and distribution of laboratory animals which contain or are produced using the Tet System.
